Chieh‐Lin Jerry Teng

National Chung Hsing University — Taiwan

Medicine · Health Sciences

20h-index1.4kcitations138works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(24), Lymphoma Diagnosis and Treatment(22), Multiple Myeloma Research and Treatments(15), Viral-associated cancers and disorders(10), Acute Lymphoblastic Leukemia research(9)

Publications138 total

Association Between Iron Overload and the Risk of Ocular Hypertension, Primary Open-Angle Glaucoma, and Normal-Tension Glaucoma
Translational Vision Science & Technology·2025Open Access
Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study
Blood·2025Open Access
Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples
Blood·2025Open Access
Doxorubicin-mediated retardation of aggresome formation enhances Carfilzomib-induced cell death synergistically by augmenting ER stress and proapoptotic signaling
European Journal of Pharmacology·2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)
Journal of the Formosan Medical Association·2025Open Access
Real World Survival Outcomes of Relapsed and Refractory Multiple Myeloma Patients Receiving Second Line Therapy and Beyond in Asia
Clinical Lymphoma Myeloma & Leukemia·2025
ALL-774: Safety and Efficacy of AZD0486 in Adolescent and Adult Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Early Results From the Phase 1/2 SYRUS Study
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: ALL-774 Safety and Efficacy of AZD0486 in Adolescent and Adult Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Early Results From the Phase 1/2 SYRUS Study
Clinical Lymphoma Myeloma & Leukemia·2025
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
Blood Advances·2025Open Access
Alisertib inhibits acute myeloid leukemia cell growth by inhibiting STAT3 activation
Toxicology and Applied Pharmacology·2025· 1 cited
Joint position statement of the diagnosis and management of light chain amyloidosis and light chain cardiac amyloidosis by the Taiwan Society of Cardiology (TSOC) and the Hematology Society of Taiwan (HST)
Journal of the Formosan Medical Association·2025Open Access
Presence of Pulmonary Hypertension Correlates with Worse Outcomes After Lung Transplantation
The Journal of Heart and Lung Transplantation·2025
Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
Hematology·2025· 1 citedOpen Access
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach
Clinical Proteomics·2025· 1 citedOpen Access
Doxorubicin synergizes bortezomib-induced multiple myeloma cell death by inhibiting aggresome formation and augmenting endoplasmic reticulum/Golgi stress and apoptosis
Journal of Translational Medicine·2024· 5 citedOpen Access
Myeloperoxidase and Thyrotropin‐Releasing Hormone Within Leukaemia Stem Cells Increased Chemosensitivity in Acute Myeloid Leukaemia
Journal of Cellular and Molecular Medicine·2024Open Access
PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2024· 6 cited
Pomalidomide Induces Myeloma Cell Death Via GPX4-Mediated Ferroptosis
Blood·2024
Doxorubicin Synergizes Bortezomib-Induced Multiple Myeloma Cell Death By Inhibiting Aggresome Formation Leading to ER Stress and Apoptosis
Blood·2024Open Access
SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade
Cell Death and Disease·2024· 14 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Wen‐Li Hwang(10), Shih‐Lan Hsu(10), Kuang‐Hsi Chang(7), Ho Lin(6), Youngsen Yang(5), Ren‐Ching Wang(5), Guang‐Yuh Hwang(5), Jui-Ting Yu(4), Chih‐Ho Lai(4), Jer‐Tsong Hsieh(4), Mei‐Chih Chen(3), Po‐Nan Wang(3), Chung Y. Hsu(3), Mei-Chih Chen(3), Muhammet Oner(3), Chia-Herng Yue(3), Wen-Li Hwang(3), Hsin‐Yi Wang(3), Jia‐Rong Tsai(3), Guan Chou(3)